Explore
Validate
LearnMA5-16034
antibody from Invitrogen Antibodies
Targeting: TERT
EST2, hEST2, TCS1, TP2, TRT
Western blot Immunocytochemistry
Immunoprecipitation Immunohistochemistry Flow cytometry Chromatin ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [2]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
- Flow cytometry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA5-16034 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- TERT Monoclonal Antibody (2C4)
- Antibody type
- Monoclonal
- Antigen
- Recombinant full-length protein
- Description
- Suggested positive control: 293T whole cell lysates, HeLa whole cell lysates, antigen standard for TERT (transient overexpression lysate).
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Isotype
- IgM
- Antibody clone number
- 2C4
- Vial size
- 100 µL
- Concentration
- 1.0 mg/mL
- Storage
- -20°C or -80°C if preferred
Submitted references Tissue Responses and Wound Healing following Laser Scleral Microporation for Presbyopia Therapy.
Telomerase Reverse Transcriptase Deficiency Prevents Neointima Formation Through Chromatin Silencing of E2F1 Target Genes.
The role of TERT-CLPTM1L SNPs, hTERT expression and telomere length in the pathogenesis of oral squamous cell carcinoma.
Liu YC, Hall B, Lwin NC, Teo EPW, Yam GHF, Hipsley A, Mehta JS
Translational vision science & technology 2020 Mar;9(4):6
Translational vision science & technology 2020 Mar;9(4):6
Telomerase Reverse Transcriptase Deficiency Prevents Neointima Formation Through Chromatin Silencing of E2F1 Target Genes.
Endorf EB, Qing H, Aono J, Terami N, Doyon G, Hyzny E, Jones KL, Findeisen HM, Bruemmer D
Arteriosclerosis, thrombosis, and vascular biology 2017 Feb;37(2):301-311
Arteriosclerosis, thrombosis, and vascular biology 2017 Feb;37(2):301-311
The role of TERT-CLPTM1L SNPs, hTERT expression and telomere length in the pathogenesis of oral squamous cell carcinoma.
Carkic J, Nikolic N, Radojevic-Skodric S, Kuzmanovic-Pficer J, Brajovic G, Antunovic M, Milasin J, Popovic B
Journal of oral science 2016;58(4):449-458
Journal of oral science 2016;58(4):449-458
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of TERT using a monoclonal antibody (Product # MA5-16034).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of TERT in MJ90 cells. Samples were incubated in TERT monoclonal antibody (Product # MA5-16034) using a dilution of 1:500.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of TERT using a monoclonal antibody (Product # MA5-16034).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of TERT in Normal human pancreas. Samples were incubated in TERT monoclonal antibody (Product # MA5-16034). Showing moderate staining of exocrine cells and a subset of islets of Langerhans.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of TERT in Human Pancreatic carcinoma. Samples were incubated in TERT monoclonal antibody (Product # MA5-16034). Showing strong staining of tumor cells.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Flow cytometry analysis of TERT using a monoclonal antibody (Product # MA5-16034).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Flow cytometry of TERT in Jurkat cells. Samples were incubated in TERT monoclonal antibody (Product # MA5-16034) and a matched isotype control using a dilution of 1 µg/mL for 30 minutes at room temperature followed by mouse IgM Alexa Fluor 488-conjugated secondary antibody. Antibody (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeablized with 0.1% saponin.
